Guenther Koehne

Jun 16, 2023 6:43 pm

Blog Posts

This is a first in human clinical trial utilizing CD34+ selected allografts with gene-edited CD33neg hematopoietic stem cells from HLA matched related or unrelated donors for patients with AML – Guenther Koehne

Headlines

NIH Launches a New Initiative to Create a 21st Century Biosafety Framework

Jun 16, 2023

Landmark Merger Launches First Institute Dedicated to Aging and Cancer

Jun 16, 2023

Gevorg Tamamyan: A Story Everyone Must Read

Jun 16, 2023

Top 10 Oncogrants of the Week: Advancing Breakthroughs in Cancer Care

Jun 16, 2023

Solange Peters Honored with the IASLC Paul A. Bunn, Jr. Scientific Award 2025

Jun 16, 2023

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30